PMID- 31861617 OWN - NLM STAT- MEDLINE DCOM- 20200928 LR - 20200928 IS - 1999-4915 (Electronic) IS - 1999-4915 (Linking) VI - 12 IP - 1 DP - 2019 Dec 19 TI - When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses. LID - 10.3390/v12010008 [doi] LID - 8 AB - Dendritic cells (DCs) are among the first cells that recognize incoming viruses at the mucosal portals of entry. Initial interaction between DCs and viruses facilitates cell activation and migration to secondary lymphoid tissues, where these antigen presenting cells (APCs) prime specific adaptive immune responses. Some viruses, however, have evolved strategies to subvert the migratory capacity of DCs as a way to disseminate infection systemically. Here we focus on the role of Siglec-1, a sialic acid-binding type I lectin receptor potently upregulated by type I interferons on DCs, that acts as a double edge sword, containing viral replication through the induction of antiviral immunity, but also favoring viral spread within tissues. Such is the case for distant enveloped viruses like human immunodeficiency virus (HIV)-1 or Ebola virus (EBOV), which incorporate sialic acid-containing gangliosides on their viral membrane and are effectively recognized by Siglec-1. Here we review how Siglec-1 is highly induced on the surface of human DCs upon viral infection, the way this impacts different antigen presentation pathways, and how enveloped viruses have evolved to exploit these APC functions as a potent dissemination strategy in different anatomical compartments. FAU - Perez-Zsolt, Daniel AU - Perez-Zsolt D AD - IrsiCaixa AIDS Research Institute, Ctra. de Canyet s/n, 08916 Badalona, Spain. AD - Universitat Autonoma de Barcelona, 08193 Bellaterra, Spain. AD - Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol, 08916 Badalona, Spain. FAU - Martinez-Picado, Javier AU - Martinez-Picado J AUID- ORCID: 0000-0002-4916-2129 AD - IrsiCaixa AIDS Research Institute, Ctra. de Canyet s/n, 08916 Badalona, Spain. AD - Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol, 08916 Badalona, Spain. AD - University of Vic-Central University of Catalonia (UVic-UCC), 08500 Vic, Spain. AD - Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Spain. FAU - Izquierdo-Useros, Nuria AU - Izquierdo-Useros N AUID- ORCID: 0000-0002-1039-1821 AD - IrsiCaixa AIDS Research Institute, Ctra. de Canyet s/n, 08916 Badalona, Spain. AD - Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol, 08916 Badalona, Spain. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20191219 PL - Switzerland TA - Viruses JT - Viruses JID - 101509722 RN - 0 (Biomarkers) RN - 0 (SIGLEC1 protein, human) RN - 0 (Sialic Acid Binding Ig-like Lectin 1) SB - IM MH - Animals MH - Antigen Presentation/immunology MH - Antigen-Presenting Cells/immunology/metabolism MH - Biomarkers MH - Dendritic Cells/*immunology/metabolism/*virology MH - Disease Resistance/genetics/immunology MH - Extracellular Vesicles/immunology/metabolism MH - Gene Expression MH - Host-Pathogen Interactions/*genetics/*immunology MH - Humans MH - Sialic Acid Binding Ig-like Lectin 1/*genetics MH - Viral Load MH - Virus Diseases/*genetics/immunology/*virology PMC - PMC7019426 OTO - NOTNLM OT - Ebola virus OT - HIV-1 OT - Siglec-1 OT - dendritic cells OT - immune evasion COIS- The authors declare two patent applications based on their work on Siglec-1 (US 62/828,195 and US 62/832,054) and declare that no other competing financial interests exist. EDAT- 2019/12/22 06:00 MHDA- 2020/09/29 06:00 PMCR- 2020/01/01 CRDT- 2019/12/22 06:00 PHST- 2019/11/13 00:00 [received] PHST- 2019/12/04 00:00 [revised] PHST- 2019/12/05 00:00 [accepted] PHST- 2019/12/22 06:00 [entrez] PHST- 2019/12/22 06:00 [pubmed] PHST- 2020/09/29 06:00 [medline] PHST- 2020/01/01 00:00 [pmc-release] AID - v12010008 [pii] AID - viruses-12-00008 [pii] AID - 10.3390/v12010008 [doi] PST - epublish SO - Viruses. 2019 Dec 19;12(1):8. doi: 10.3390/v12010008.